25 XP   0   0   10

VIVA Biotech Holdings
Buy, Hold or Sell?

Let's analyse VIVA Biotech Holdings together

PenkeI guess you are interested in VIVA Biotech Holdings. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of VIVA Biotech Holdings. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about VIVA Biotech Holdings

I send you an email if I find something interesting about VIVA Biotech Holdings.

Quick analysis of VIVA Biotech Holdings (30 sec.)










What can you expect buying and holding a share of VIVA Biotech Holdings? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
71.4%

What is your share worth?

Current worth
HK$1.82
Expected worth in 1 year
HK$1.20
How sure are you?
85.7%

+ What do you gain per year?

Total Gains per Share
HK$-0.62
Return On Investment
-131.1%

For what price can you sell your share?

Current Price per Share
HK$0.48
Expected price per share
HK$0 - HK$0.67
How sure are you?
50%

1. Valuation of VIVA Biotech Holdings (5 min.)




Live pricePrice per Share (EOD)

HK$0.48

Intrinsic Value Per Share

HK$-0.68 - HK$0.30

Total Value Per Share

HK$1.13 - HK$2.12

2. Growth of VIVA Biotech Holdings (5 min.)




Is VIVA Biotech Holdings growing?

Current yearPrevious yearGrowGrow %
How rich?$497.3m$539.9m-$42.5m-8.6%

How much money is VIVA Biotech Holdings making?

Current yearPrevious yearGrowGrow %
Making money-$67.4m$36.7m-$104.2m-154.4%
Net Profit Margin-22.2%13.7%--

How much money comes from the company's main activities?

3. Financial Health of VIVA Biotech Holdings (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of VIVA Biotech Holdings? (5 min.)

Welcome investor! VIVA Biotech Holdings's management wants to use your money to grow the business. In return you get a share of VIVA Biotech Holdings.

What can you expect buying and holding a share of VIVA Biotech Holdings?

First you should know what it really means to hold a share of VIVA Biotech Holdings. And how you can make/lose money.

Speculation

The Price per Share of VIVA Biotech Holdings is HK$0.475. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of VIVA Biotech Holdings.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in VIVA Biotech Holdings, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$1.82. Based on the TTM, the Book Value Change Per Share is HK$-0.16 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of VIVA Biotech Holdings.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.03-6.6%-0.03-6.6%0.023.6%0.00-0.7%0.00-0.3%
Usd Book Value Change Per Share-0.02-4.2%-0.02-4.2%0.012.1%0.049.4%0.037.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.2%0.000.6%0.000.5%
Usd Total Gains Per Share-0.02-4.2%-0.02-4.2%0.012.3%0.0510.0%0.047.4%
Usd Price Per Share0.22-0.22-0.60-0.51-0.37-
Price to Earnings Ratio-7.09--7.09-35.08-2.82-2.02-
Price-to-Total Gains Ratio-11.24--11.24-54.04-14.29-14.29-
Price to Book Ratio0.96-0.96-2.39-2.65-1.89-
Price-to-Total Gains Ratio-11.24--11.24-54.04-14.29-14.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0606575
Number of shares16486
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.04
Usd Total Gains Per Share-0.020.05
Gains per Quarter (16486 shares)-327.77779.70
Gains per Year (16486 shares)-1,311.093,118.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1311-132118629333109
20-2622-263237258656228
30-3933-394355887989347
40-5244-52547441173112466
50-6555-65659301466415585
60-7867-787611161759618704
70-9178-918713022052921823
80-10489-1049814882346224942
90-11800-1180916742639528061
100-13111-1312018602932731180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.02.00.071.4%5.02.00.071.4%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%6.01.00.085.7%6.01.00.085.7%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%5.00.02.071.4%5.00.02.071.4%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%6.01.00.085.7%6.01.00.085.7%

Fundamentals of VIVA Biotech Holdings

About VIVA Biotech Holdings

Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, include protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; antibody drug research and development services, include antigen preparation, multi-species discovery, monoclonal antibodies, antibodies functional screening and identification, antibody engineering transformation, antibody characteristics, and antibody cell line engineering transformation, as well as offers technology platforms, such as hybridoma, phage and yeast display, mammalian display, VHH antibody technology, high throughput sequencing, computer-aided drug design, HDX-MS, crystal structure analysis of protein, and SPR technology; and PROTAC/molecular glue services. It also provides cell lines, crystal structures, GPCR proteins, antibodies, and proteins. In addition, the company offers contract development and manufacturing services for small molecule active pharmaceutical ingredients (APIs) and intermediates; and trades in APIs, intermediates, and formulations, as well as equity for service. Further, it provides research service; laboratory rental services; and project management and bidding services, as well as sells compounds. Viva Biotech Holdings was incorporated in 2008 and is headquartered in Shanghai, China.

Fundamental data was last updated by Penke on 2024-04-16 02:36:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of VIVA Biotech Holdings.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit VIVA Biotech Holdings earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare VIVA Biotech Holdings to the Biotechnology industry mean.
  • A Net Profit Margin of -22.2% means that $-0.22 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of VIVA Biotech Holdings:

  • The MRQ is -22.2%. The company is making a huge loss. -2
  • The TTM is -22.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-22.2%TTM-22.2%0.0%
TTM-22.2%YOY13.7%-35.9%
TTM-22.2%5Y12.3%-34.5%
5Y12.3%10Y19.7%-7.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.2%-200.1%+177.9%
TTM-22.2%-216.8%+194.6%
YOY13.7%-288.3%+302.0%
5Y12.3%-449.1%+461.4%
10Y19.7%-605.5%+625.2%
1.1.2. Return on Assets

Shows how efficient VIVA Biotech Holdings is using its assets to generate profit.

  • Above 5% is considered healthy but always compare VIVA Biotech Holdings to the Biotechnology industry mean.
  • -6.2% Return on Assets means that VIVA Biotech Holdings generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of VIVA Biotech Holdings:

  • The MRQ is -6.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.2%TTM-6.2%0.0%
TTM-6.2%YOY3.3%-9.5%
TTM-6.2%5Y4.3%-10.5%
5Y4.3%10Y11.2%-6.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.2%-13.3%+7.1%
TTM-6.2%-12.8%+6.6%
YOY3.3%-11.7%+15.0%
5Y4.3%-13.9%+18.2%
10Y11.2%-15.7%+26.9%
1.1.3. Return on Equity

Shows how efficient VIVA Biotech Holdings is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare VIVA Biotech Holdings to the Biotechnology industry mean.
  • -13.6% Return on Equity means VIVA Biotech Holdings generated $-0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of VIVA Biotech Holdings:

  • The MRQ is -13.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.6%TTM-13.6%0.0%
TTM-13.6%YOY6.8%-20.4%
TTM-13.6%5Y6.2%-19.7%
5Y6.2%10Y15.2%-9.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.6%-16.9%+3.3%
TTM-13.6%-16.1%+2.5%
YOY6.8%-15.1%+21.9%
5Y6.2%-19.3%+25.5%
10Y15.2%-20.2%+35.4%

1.2. Operating Efficiency of VIVA Biotech Holdings.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient VIVA Biotech Holdings is operating .

  • Measures how much profit VIVA Biotech Holdings makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare VIVA Biotech Holdings to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of VIVA Biotech Holdings:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY11.3%-11.3%
TTM-5Y11.4%-11.4%
5Y11.4%10Y18.0%-6.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY11.3%-298.2%+309.5%
5Y11.4%-492.1%+503.5%
10Y18.0%-632.4%+650.4%
1.2.2. Operating Ratio

Measures how efficient VIVA Biotech Holdings is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.53 means that the operating costs are $1.53 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of VIVA Biotech Holdings:

  • The MRQ is 1.526. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.526. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.526TTM1.5260.000
TTM1.526YOY1.561-0.036
TTM1.5265Y1.238+0.288
5Y1.23810Y1.072+0.166
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5263.231-1.705
TTM1.5263.310-1.784
YOY1.5613.890-2.329
5Y1.2385.739-4.501
10Y1.0727.876-6.804

1.3. Liquidity of VIVA Biotech Holdings.

1.3. Liquidity
1.3.1. Current Ratio

Measures if VIVA Biotech Holdings is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.73 means the company has $0.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of VIVA Biotech Holdings:

  • The MRQ is 0.725. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.725. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.725TTM0.7250.000
TTM0.725YOY2.141-1.415
TTM0.7255Y5.620-4.895
5Y5.62010Y4.907+0.713
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7253.890-3.165
TTM0.7254.173-3.448
YOY2.1415.344-3.203
5Y5.6206.126-0.506
10Y4.9076.448-1.541
1.3.2. Quick Ratio

Measures if VIVA Biotech Holdings is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare VIVA Biotech Holdings to the Biotechnology industry mean.
  • A Quick Ratio of 0.42 means the company can pay off $0.42 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of VIVA Biotech Holdings:

  • The MRQ is 0.416. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.416. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.416TTM0.4160.000
TTM0.416YOY1.321-0.905
TTM0.4165Y4.940-4.525
5Y4.94010Y4.288+0.652
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4163.514-3.098
TTM0.4163.998-3.582
YOY1.3215.380-4.059
5Y4.9406.105-1.165
10Y4.2886.404-2.116

1.4. Solvency of VIVA Biotech Holdings.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of VIVA Biotech Holdings assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare VIVA Biotech Holdings to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.54 means that VIVA Biotech Holdings assets are financed with 54.5% credit (debt) and the remaining percentage (100% - 54.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of VIVA Biotech Holdings:

  • The MRQ is 0.545. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.545. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.545TTM0.5450.000
TTM0.545YOY0.514+0.031
TTM0.5455Y0.437+0.108
5Y0.43710Y0.383+0.054
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5450.339+0.206
TTM0.5450.336+0.209
YOY0.5140.271+0.243
5Y0.4370.366+0.071
10Y0.3830.389-0.006
1.4.2. Debt to Equity Ratio

Measures if VIVA Biotech Holdings is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare VIVA Biotech Holdings to the Biotechnology industry mean.
  • A Debt to Equity ratio of 119.7% means that company has $1.20 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of VIVA Biotech Holdings:

  • The MRQ is 1.197. The company is able to pay all its debts with equity. +1
  • The TTM is 1.197. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.197TTM1.1970.000
TTM1.197YOY1.056+0.142
TTM1.1975Y0.919+0.278
5Y0.91910Y0.750+0.169
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1970.388+0.809
TTM1.1970.402+0.795
YOY1.0560.335+0.721
5Y0.9190.426+0.493
10Y0.7500.461+0.289

2. Market Valuation of VIVA Biotech Holdings

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings VIVA Biotech Holdings generates.

  • Above 15 is considered overpriced but always compare VIVA Biotech Holdings to the Biotechnology industry mean.
  • A PE ratio of -7.09 means the investor is paying $-7.09 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of VIVA Biotech Holdings:

  • The EOD is -1.925. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.092. Based on the earnings, the company is expensive. -2
  • The TTM is -7.092. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.925MRQ-7.092+5.167
MRQ-7.092TTM-7.0920.000
TTM-7.092YOY35.082-42.174
TTM-7.0925Y2.825-9.917
5Y2.82510Y2.018+0.807
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.925-2.264+0.339
MRQ-7.092-2.629-4.463
TTM-7.092-2.680-4.412
YOY35.082-4.145+39.227
5Y2.825-6.257+9.082
10Y2.018-6.254+8.272
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of VIVA Biotech Holdings:

  • The EOD is 6.898. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 25.414. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 25.414. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD6.898MRQ25.414-18.516
MRQ25.414TTM25.4140.000
TTM25.414YOY-19.114+44.527
TTM25.4145Y-119.245+144.659
5Y-119.24510Y-85.175-34.070
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.898-2.973+9.871
MRQ25.414-3.333+28.747
TTM25.414-3.553+28.967
YOY-19.114-5.605-13.509
5Y-119.245-8.376-110.869
10Y-85.175-8.865-76.310
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of VIVA Biotech Holdings is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.96 means the investor is paying $0.96 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of VIVA Biotech Holdings:

  • The EOD is 0.261. Based on the equity, the company is cheap. +2
  • The MRQ is 0.962. Based on the equity, the company is cheap. +2
  • The TTM is 0.962. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.261MRQ0.962-0.701
MRQ0.962TTM0.9620.000
TTM0.962YOY2.386-1.424
TTM0.9625Y2.651-1.689
5Y2.65110Y1.894+0.758
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.2611.896-1.635
MRQ0.9622.115-1.153
TTM0.9622.093-1.131
YOY2.3862.884-0.498
5Y2.6513.542-0.891
10Y1.8943.916-2.022
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of VIVA Biotech Holdings compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.156-0.1560%0.079-297%0.348-145%0.260-160%
Book Value Per Share--1.8181.8180%1.974-8%1.342+35%0.975+86%
Current Ratio--0.7250.7250%2.141-66%5.620-87%4.907-85%
Debt To Asset Ratio--0.5450.5450%0.514+6%0.437+25%0.383+42%
Debt To Equity Ratio--1.1971.1970%1.056+13%0.919+30%0.750+60%
Dividend Per Share----0%0.008-100%0.022-100%0.017-100%
Eps---0.247-0.2470%0.134-284%-0.025-90%-0.011-95%
Free Cash Flow Per Share--0.0690.0690%-0.246+458%-0.100+245%-0.070+201%
Free Cash Flow To Equity Per Share---0.003-0.0030%-0.576+16973%0.473-101%0.339-101%
Gross Profit Margin--1.0001.0000%1.0000%0.995+0%0.985+2%
Intrinsic Value_10Y_max--0.298--------
Intrinsic Value_10Y_min---0.685--------
Intrinsic Value_1Y_max---0.072--------
Intrinsic Value_1Y_min---0.137--------
Intrinsic Value_3Y_max---0.139--------
Intrinsic Value_3Y_min---0.354--------
Intrinsic Value_5Y_max---0.112--------
Intrinsic Value_5Y_min---0.508--------
Market Cap1017340742.400-268%3748097472.0003748097472.0000%10087736624.640-63%8635616575.488-57%6168297553.920-39%
Net Profit Margin---0.222-0.2220%0.137-263%0.123-281%0.197-213%
Operating Margin----0%0.113-100%0.114-100%0.180-100%
Operating Ratio--1.5261.5260%1.561-2%1.238+23%1.072+42%
Pb Ratio0.261-268%0.9620.9620%2.386-60%2.651-64%1.894-49%
Pe Ratio-1.925+73%-7.092-7.0920%35.082-120%2.825-351%2.018-451%
Price Per Share0.475-268%1.7501.7500%4.710-63%4.032-57%2.880-39%
Price To Free Cash Flow Ratio6.898-268%25.41425.4140%-19.114+175%-119.245+569%-85.175+435%
Price To Total Gains Ratio-3.051+73%-11.240-11.2400%54.035-121%14.289-179%14.289-179%
Quick Ratio--0.4160.4160%1.321-69%4.940-92%4.288-90%
Return On Assets---0.062-0.0620%0.033-287%0.043-243%0.112-155%
Return On Equity---0.136-0.1360%0.068-300%0.062-320%0.152-189%
Total Gains Per Share---0.156-0.1560%0.087-279%0.370-142%0.277-156%
Usd Book Value--497331864.815497331864.8150%539914300.320-8%367095549.396+35%266729804.515+86%
Usd Book Value Change Per Share---0.020-0.0200%0.010-297%0.044-145%0.033-160%
Usd Book Value Per Share--0.2320.2320%0.252-8%0.171+35%0.125+86%
Usd Dividend Per Share----0%0.001-100%0.003-100%0.002-100%
Usd Eps---0.032-0.0320%0.017-284%-0.003-90%-0.001-95%
Usd Free Cash Flow--18833748.12418833748.1240%-67396090.778+458%-27270324.692+245%-19030508.889+201%
Usd Free Cash Flow Per Share--0.0090.0090%-0.031+458%-0.013+245%-0.009+201%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%-0.074+16973%0.060-101%0.043-101%
Usd Market Cap129914412.804-268%478632047.174478632047.1740%1288203966.967-63%1102768236.690-57%787691597.636-39%
Usd Price Per Share0.061-268%0.2230.2230%0.601-63%0.515-57%0.368-39%
Usd Profit---67486257.500-67486257.5000%36719624.200-284%-6931223.980-90%-3113216.543-95%
Usd Revenue--303878878.700303878878.7000%268691399.100+13%145929481.480+108%108700046.043+180%
Usd Total Gains Per Share---0.020-0.0200%0.011-279%0.047-142%0.035-156%
 EOD+4 -4MRQTTM+0 -0YOY+10 -255Y+11 -2510Y+11 -25

3.2. Fundamental Score

Let's check the fundamental score of VIVA Biotech Holdings based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.925
Price to Book Ratio (EOD)Between0-10.261
Net Profit Margin (MRQ)Greater than0-0.222
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.416
Current Ratio (MRQ)Greater than10.725
Debt to Asset Ratio (MRQ)Less than10.545
Debt to Equity Ratio (MRQ)Less than11.197
Return on Equity (MRQ)Greater than0.15-0.136
Return on Assets (MRQ)Greater than0.05-0.062
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of VIVA Biotech Holdings based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.735
Ma 20Greater thanMa 500.477
Ma 50Greater thanMa 1000.531
Ma 100Greater thanMa 2000.718
OpenGreater thanClose0.435
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Retained Earnings  180,789277,464458,253-432,95325,300352,927378,226-570,964-192,738
Net Working Capital  214,684888,9051,103,5891,722,5992,826,188-1,684,0091,142,179-1,934,923-792,744
EBITDA  39,78938,26378,052116,882194,934335,875530,809-619,846-89,037
Operating Income  30,24113,76744,00881,007125,015268,319393,334-677,875-284,541



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,920,855
Total Liabilities4,316,141
Total Stockholder Equity3,604,714
 As reported
Total Liabilities 4,316,141
Total Stockholder Equity+ 3,604,714
Total Assets = 7,920,855

Assets

Total Assets7,920,855
Total Current Assets1,938,807
Long-term Assets5,982,048
Total Current Assets
Cash And Cash Equivalents 678,569
Net Receivables 432,486
Inventory 326,031
Other Current Assets 420,883
Total Current Assets  (as reported)1,938,807
Total Current Assets  (calculated)1,857,969
+/- 80,838
Long-term Assets
Property Plant Equipment 1,964,417
Goodwill 2,156,419
Intangible Assets 476,061
Other Assets 359,147
Long-term Assets  (as reported)5,982,048
Long-term Assets  (calculated)4,956,044
+/- 1,026,004

Liabilities & Shareholders' Equity

Total Current Liabilities2,672,557
Long-term Liabilities1,643,584
Total Stockholder Equity3,604,714
Total Current Liabilities
Short Long Term Debt 1,913,910
Accounts payable 326,130
Total Current Liabilities  (as reported)2,672,557
Total Current Liabilities  (calculated)2,240,040
+/- 432,517
Long-term Liabilities
Long term Debt Total 906,760
Capital Lease Obligations Min Short Term Debt28,071
Long-term Liabilities Other 571,500
Long-term Liabilities  (as reported)1,643,584
Long-term Liabilities  (calculated)1,506,331
+/- 137,253
Total Stockholder Equity
Common Stock326
Retained Earnings -178,395
Capital Surplus 3,636,950
Other Stockholders Equity 280,484
Total Stockholder Equity (as reported)3,604,714
Total Stockholder Equity (calculated)3,739,365
+/- 134,651
Other
Capital Stock326
Cash And Equivalents678,569
Cash and Short Term Investments 678,569
Common Stock Shares Outstanding 1,915,437
Liabilities and Stockholders Equity 7,920,855
Net Debt 2,116,300
Net Invested Capital 6,399,583
Net Working Capital -733,750
Property Plant and Equipment Gross 2,215,571



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
101,821
202,402
529,339
1,898,785
8,154,080
8,044,758
7,920,855
7,920,8558,044,7588,154,0801,898,785529,339202,402101,821
   > Total Current Assets 
65,164
83,447
241,170
1,094,426
3,351,544
1,983,785
1,938,807
1,938,8071,983,7853,351,5441,094,426241,17083,44765,164
       Cash And Cash Equivalents 
13,425
29,766
155,554
904,091
2,308,452
800,947
678,569
678,569800,9472,308,452904,091155,55429,76613,425
       Short-term Investments 
0
3,500
0
29,629
49,500
0
0
0049,50029,62903,5000
       Net Receivables 
42,539
33,034
58,253
68,011
383,855
423,010
432,486
432,486423,010383,85568,01158,25333,03442,539
       Inventory 
1,013
3,323
4,900
8,530
164,745
231,721
326,031
326,031231,721164,7458,5304,9003,3231,013
       Other Current Assets 
6,782
11,856
19,555
82,822
439,061
411,954
420,883
420,883411,954439,06182,82219,55511,8566,782
   > Long-term Assets 
36,657
118,955
288,169
804,359
4,802,536
6,060,973
5,982,048
5,982,0486,060,9734,802,536804,359288,169118,95536,657
       Property Plant Equipment 
21,343
34,400
66,899
156,986
737,010
1,723,901
1,964,417
1,964,4171,723,901737,010156,98666,89934,40021,343
       Goodwill 
0
0
0
0
1,847,723
2,156,419
2,156,419
2,156,4192,156,4191,847,7230000
       Long Term Investments 
12,122
77,569
210,017
0
0
0
0
0000210,01777,56912,122
       Intangible Assets 
0
0
0
0
469,462
531,444
476,061
476,061531,444469,4620000
       Other Assets 
3,192
6,986
11,253
20,291
823,809
402,479
359,147
359,147402,479823,80920,29111,2536,9863,192
> Total Liabilities 
25,319
49,640
277,897
121,391
4,397,249
4,131,402
4,316,141
4,316,1414,131,4024,397,249121,391277,89749,64025,319
   > Total Current Liabilities 
16,320
36,991
42,462
72,963
735,672
926,603
2,672,557
2,672,557926,603735,67272,96342,46236,99116,320
       Short-term Debt 
447
3,500
497
29,629
155,554
0
0
00155,55429,6294973,500447
       Short Long Term Debt 
447
12,583
497
525
155,554
233,052
1,913,910
1,913,910233,052155,55452549712,583447
       Accounts payable 
1,575
3,767
4,685
7,552
295,704
281,053
326,130
326,130281,053295,7047,5524,6853,7671,575
       Other Current Liabilities 
9,198
13,842
31,027
19,685
125,321
300,956
0
0300,956125,32119,68531,02713,8429,198
   > Long-term Liabilities 
8,999
12,649
235,435
48,428
3,661,577
3,204,799
1,643,584
1,643,5843,204,7993,661,57748,428235,43512,6498,999
       Long term Debt Total 
2,833
2,362
1,865
24,424
2,802,546
2,415,953
906,760
906,7602,415,9532,802,54624,4241,8652,3622,833
       Other Liabilities 
6,166
10,287
12,970
24,004
859,031
788,846
0
0788,846859,03124,00412,97010,2876,166
> Total Stockholder Equity
76,502
152,762
251,442
1,777,394
3,756,831
3,913,356
3,604,714
3,604,7143,913,3563,756,8311,777,394251,442152,76276,502
   Common Stock
120
120
164
261
323
326
326
326326323261164120120
   Retained Earnings 
13,699
83,720
167,335
424,151
23,417
350,080
-178,395
-178,395350,08023,417424,151167,33583,72013,699
   Capital Surplus 
13,590
13,590
47,251
1,298,673
3,650,761
3,636,950
3,636,950
3,636,9503,636,9503,650,7611,298,67347,25113,59013,590
   Treasury Stock0-134,651-52,6830000
   Other Stockholders Equity 
45,588
45,588
20,485
29,046
95,896
60,651
280,484
280,48460,65195,89629,04620,48545,58845,588



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue2,379,631
Cost of Revenue-1,563,952
Gross Profit815,679815,679
 
Operating Income (+$)
Gross Profit815,679
Operating Expense-2,066,190
Operating Income-284,541-1,250,511
 
Operating Expense (+$)
Research Development135,835
Selling General Administrative404,453
Selling And Marketing Expenses-
Operating Expense2,066,190540,288
 
Net Interest Income (+$)
Interest Income184,674
Interest Expense-529,902
Other Finance Cost-182,160
Net Interest Income-163,068
 
Pretax Income (+$)
Operating Income-284,541
Net Interest Income-163,068
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-459,165-284,541
EBIT - interestExpense = -529,902
-528,475
1,427
Interest Expense529,902
Earnings Before Interest and Taxes (EBIT)-70,737
Earnings Before Interest and Taxes (EBITDA)-89,037
 
After tax Income (+$)
Income Before Tax-459,165
Tax Provision-45,055
Net Income From Continuing Ops-504,220-504,220
Net Income-528,475
Net Income Applicable To Common Shares-528,475
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-163,068
 

Technical Analysis of VIVA Biotech Holdings
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of VIVA Biotech Holdings. The general trend of VIVA Biotech Holdings is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine VIVA Biotech Holdings's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of VIVA Biotech Holdings.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.48 < 0.5 < 0.67.

The bearish price targets are: .

Tweet this
VIVA Biotech Holdings Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of VIVA Biotech Holdings. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

VIVA Biotech Holdings Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of VIVA Biotech Holdings. The current macd is -0.03083868.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the VIVA Biotech Holdings price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for VIVA Biotech Holdings. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the VIVA Biotech Holdings price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
VIVA Biotech Holdings Daily Moving Average Convergence/Divergence (MACD) ChartVIVA Biotech Holdings Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of VIVA Biotech Holdings. The current adx is 17.26.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell VIVA Biotech Holdings shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
VIVA Biotech Holdings Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of VIVA Biotech Holdings. The current sar is 0.41.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
VIVA Biotech Holdings Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of VIVA Biotech Holdings. The current rsi is 46.73. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
VIVA Biotech Holdings Daily Relative Strength Index (RSI) ChartVIVA Biotech Holdings Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of VIVA Biotech Holdings. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the VIVA Biotech Holdings price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
VIVA Biotech Holdings Daily Stochastic Oscillator ChartVIVA Biotech Holdings Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of VIVA Biotech Holdings. The current cci is -32.22886113.

VIVA Biotech Holdings Daily Commodity Channel Index (CCI) ChartVIVA Biotech Holdings Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of VIVA Biotech Holdings. The current cmo is 4.82209288.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
VIVA Biotech Holdings Daily Chande Momentum Oscillator (CMO) ChartVIVA Biotech Holdings Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of VIVA Biotech Holdings. The current willr is -27.77777778.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that VIVA Biotech Holdings is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
VIVA Biotech Holdings Daily Williams %R ChartVIVA Biotech Holdings Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of VIVA Biotech Holdings.

VIVA Biotech Holdings Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of VIVA Biotech Holdings. The current atr is 0.03645436.

VIVA Biotech Holdings Daily Average True Range (ATR) ChartVIVA Biotech Holdings Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of VIVA Biotech Holdings. The current obv is -221,459,446.

VIVA Biotech Holdings Daily On-Balance Volume (OBV) ChartVIVA Biotech Holdings Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of VIVA Biotech Holdings. The current mfi is 37.84.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
VIVA Biotech Holdings Daily Money Flow Index (MFI) ChartVIVA Biotech Holdings Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for VIVA Biotech Holdings.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

VIVA Biotech Holdings Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of VIVA Biotech Holdings based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.735
Ma 20Greater thanMa 500.477
Ma 50Greater thanMa 1000.531
Ma 100Greater thanMa 2000.718
OpenGreater thanClose0.435
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of VIVA Biotech Holdings with someone you think should read this too:
  • Are you bullish or bearish on VIVA Biotech Holdings? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about VIVA Biotech Holdings? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about VIVA Biotech Holdings

I send you an email if I find something interesting about VIVA Biotech Holdings.


Comments

How you think about this?

Leave a comment

Stay informed about VIVA Biotech Holdings.

Receive notifications about VIVA Biotech Holdings in your mailbox!